0 items USD 0.00Search
Your search for "mantle will lymphoma" gave back 46531 results.
The “Marginal Zone Lymphoma Treatment Industry Forecast” looks at past sales and reviews total world Marginal Zone Lymphoma Treatment sales in 2022,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “Cutaneous Cell Lymphoma Treatment Industry Forecast” looks at past sales and reviews total world Cutaneous Cell Lymphoma Treatment sales in 2022...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Indolent Lymphoma Treatment Industry Forecast” looks at past sales and reviews total world Indolent Lymphoma Treatment sales in 2022, providing...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma (NHL), and one of the subtypes of T-cell lymphoma. The “Anaplastic Large...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Marginal zone lymphoma (MZL) is a group of indolent (slow growing) NHL B-cell lymphomas, which account for approximately eight percent of all NHL...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The characterization of anaplastic lymphoma kinase (ALK) gene and their role in the development and progression of ALK positive cancer has...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma (NHL), and one of the subtypes of T-cell lymphoma. The “Anaplastic Large...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “T-Cell Lymphoma Treatment Industry Forecast” looks at past sales and reviews total world T-Cell Lymphoma Treatment sales in 2022, providing a...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The global Intraocular Lymphoma Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
March 2023
Price: USD 4,480.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system...
Catalog:
LPI
March 2023
Price: USD 3,660.00
ALK inhibitors are potential anti-cancer drugs that act on tumours with variations of anaplastic lymphoma kinase (ALK) such as an EML4-ALK...
Catalog:
LPI
February 2023
Price: USD 3,660.00
